title: Cystic Fibrosis: The Dawn of a New Therapeutic Era.
authors.affiliation: 1 Division of Pediatric Pulmonology, Department of Pediatrics, and.|2 Cystic Fibrosis Foundation Therapeutics Development Network Coordinating Center, Seattle Children's Research Institute, Seattle, Washington.
authors.forename: Sonya L
authors.initials: SL
authors.lastname: Heltshe
authors.affiliation: 1 Division of Pediatric Pulmonology, Department of Pediatrics, and.
authors.forename: Jonathan
authors.initials: J
authors.lastname: Cogen
authors.affiliation: 3 Division of Pulmonary and Critical Care Medicine, Department of Medicine, University of Washington, Seattle, Washington; and.
authors.forename: Kathleen J
authors.initials: KJ
authors.lastname: Ramos
authors.affiliation: 1 Division of Pediatric Pulmonology, Department of Pediatrics, and.|3 Division of Pulmonary and Critical Care Medicine, Department of Medicine, University of Washington, Seattle, Washington; and.|2 Cystic Fibrosis Foundation Therapeutics Development Network Coordinating Center, Seattle Children's Research Institute, Seattle, Washington.
authors.forename: Christopher H
authors.initials: CH
authors.lastname: Goss
mesh_terms: D000627:Aminophenols / Q000494:pharmacology / Q000627:therapeutic use*; D000631:Aminopyridines / Q000494:pharmacology / Q000627:therapeutic use*; D052117:Benzodioxoles / Q000494:pharmacology / Q000627:therapeutic use*; D065101:Chloride Channel Agonists / Q000494:pharmacology / Q000627:therapeutic use; D003550:Cystic Fibrosis / Q000175:diagnosis / Q000188:drug therapy* / Q000235:genetics / Q000503:physiopathology; D019005:Cystic Fibrosis Transmembrane Conductance Regulator / Q000187:drug effects* / Q000235:genetics / Q000502:physiology; D004338:Drug Combinations; D042241:Early Diagnosis; D015316:Genetic Therapy / Q000379:methods / Q000639:trends*; D006801:Humans; D015363:Quinolones / Q000494:pharmacology / Q000627:therapeutic use*; D015996:Survival Rate / Q000639:trends
chemical_list: D000627:Aminophenols; D000631:Aminopyridines; D052117:Benzodioxoles; D065101:Chloride Channel Agonists; D004338:Drug Combinations; D015363:Quinolones; C000599212:lumacaftor, ivacaftor drug combination; D019005:Cystic Fibrosis Transmembrane Conductance Regulator; C545203:ivacaftor